Publication | Closed Access

The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE−/− mice through inhibiting vascular inflammatory response

InflammationVascular DiseaseInflammatory DiseaseVascular Inflammatory ResponseAtherosclerosisApoe−/− MiceMedicineImmunologyVascular PharmacologyChronic InflammationSirt1 Activator Srt1720Endothelial DysfunctionVascular BiologyPharmacologyCell BiologyCell Signaling